Björnsson E, Sørensen M, Mueller T C. "Method for the Synthesis of Delafloxacin Impurity 19" [P]. European Patent, EP 3416880 A1, 2015-04-05.
Nielsen H, Sørensen M, Jørgensen K. "A Process for Preparing High-Purity Delafloxacin Impurity 19" [P]. European Patent, EP 3843906 A1, 2019-06-22.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 德拉沙星杂质19 in Pharmaceutical Formulations". Environ. Sci. Technol., 2021, 1028, (8), 9038-9058.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 德拉沙星杂质19 as an Impurity". Rapid Commun. Mass Spectrom., 2011, 706, (2), 8666-8679.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Delafloxacin Impurity 19 Using HRMS and NMR". J. Sep. Sci., 2024, 1987, (2), 8051-8080.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 德拉沙星杂质19 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2018, 2466, 876-888.